Pinealon Peptide Research: 7 Key Findings on EDR, Gene Regulation and Neuroprotection
Exploring the Glu–Asp–Arg tripeptide, oxidative stress, neuronal survival, DNA interactions, experimental brain ageing and the limits of human evidence.
Pinealon peptide research examines a synthetic three-amino-acid compound known as Glu–Asp–Arg, or EDR. Developed within the Russian short-peptide bioregulation research programme associated with Vladimir Khavinson and colleagues, Pinealon has been studied in cellular and animal models involving oxidative stress, neuronal injury and changes in gene-associated processes.
Unlike larger signalling peptides that act through well-characterised cell-surface receptors, Pinealon has been discussed as a potential regulator of intracellular processes. Some researchers have proposed that short peptides can interact with DNA or chromatin-associated structures and thereby influence gene expression.
That hypothesis is scientifically interesting, but it requires careful interpretation.
Experiments involving isolated DNA, cultured cells and animal tissues do not establish that Pinealon produces predictable changes in human gene expression. Likewise, laboratory evidence of reduced oxidative stress does not demonstrate prevention of dementia, restoration of memory or reversal of brain ageing.
A 2011 study reported that Pinealon reduced reactive oxygen species accumulation and necrotic cell death in several experimental cell systems. Earlier animal research also described changes in responses to hypoxic stress.
These observations form an important foundation for Pinealon peptide research, although independent replication and controlled human trials remain major evidence gaps.
This article examines seven findings, distinguishes direct observations from proposed mechanisms and explains the analytical standards needed for reliable EDR laboratory research.
1. Pinealon Peptide Research: Structure, Sequence and Scientific Identity
Pinealon is a synthetic tripeptide consisting of three amino acids:
Glu–Asp–Arg
Its single-letter amino acid sequence is:
EDR
The residues are glutamic acid, aspartic acid and arginine. Pinealon peptide research
Pinealon belongs to a group of short peptides examined in the research programme often associated with the term peptide bioregulators.
That term describes a research concept rather than a regulatory classification establishing clinical effectiveness.
Pinealon Molecular Specifications
| Property | Scientific information |
|---|---|
| Compound | Pinealon |
| Alternative designation | EDR peptide |
| Research code | T-33 |
| Peptide class | Synthetic tripeptide |
| Sequence | Glu–Asp–Arg |
| Single-letter sequence | EDR |
| Amino acid length | 3 residues |
| Molecular formula | C15H26N6O8 |
| Approximate molecular mass | 418.4 Da |
| CAS number | 175175-23-2 |
| PubChem CID | 10273502 |
| Main research fields | Oxidative stress, neuronal cell biology and gene regulation |
| FDA status | Not an FDA-approved medicine |
The molecular formula and mass refer to the unmodified peptide. Counterions, water and other constituents may affect the composition of a supplied research material.
What Makes EDR Chemically Distinct?
The sequence combines two acidic residues with one basic residue.
Glutamic acid and aspartic acid contain carboxyl-containing side chains, while arginine contains a positively charged guanidinium group under many physiological conditions.
These characteristics influence the peptide’s overall charge and potential molecular interactions. Pinealon peptide research
Is Pinealon a Naturally Occurring Human Hormone?
No established evidence identifies the complete EDR tripeptide as a conventional human hormone with a defined endocrine receptor system.
It is best described as a synthetic research peptide.
Is Pinealon Extracted From the Pineal Gland?
No.
Despite the name, chemically synthesised Pinealon is not a pineal gland extract.
Its name should not be taken as evidence that it directly controls melatonin production or human circadian rhythms.
Why Structure Matters
The molecular identity of a three-residue peptide is precise.
A change in residue order, terminal modification or chemical form can alter its characteristics. Pinealon peptide research
Accurate identification is therefore a foundational requirement in Pinealon peptide research.
2. Pinealon Peptide Research and Oxidative Stress
One of the strongest areas of experimental evidence involves reactive oxygen species, commonly abbreviated ROS.
ROS are chemically reactive oxygen-containing molecules produced through normal cellular processes.
At controlled levels, they participate in signalling. Excessive or poorly regulated ROS production can contribute to cellular injury.
The 2011 Cell Study
Khavinson and colleagues published a study in Rejuvenation Research examining Pinealon in several cellular systems.
The researchers studied cerebellar granule cells, neutrophils and PC12 cells exposed to conditions associated with oxidative stress.
They reported that Pinealon restricted ROS accumulation in a concentration-dependent manner. Pinealon peptide research
What Are Cerebellar Granule Cells?
Cerebellar granule cells are neurons found in the cerebellum.
They are commonly used in laboratory studies of neuronal development, excitotoxicity and cellular stress.
What Are PC12 Cells?
PC12 cells originate from a rat pheochromocytoma.
They are widely used as an experimental model for selected neuronal characteristics.
However, they are not equivalent to normal human neurons.
What Did the Study Measure?
The investigators assessed ROS accumulation and cell viability using experimental assays.
They also examined changes in signalling and cell-cycle-associated measurements. Pinealon peptide research
Did Pinealon Eliminate All Oxidative Stress?
No.
The reported results demonstrated changes under specific experimental conditions.
They did not establish that Pinealon universally prevents oxidative damage.
Is Pinealon a Direct Antioxidant?
The term antioxidant requires qualification.
A compound can reduce an oxidative-stress measurement through several mechanisms, including changes in cellular signalling or endogenous protective systems.
The experiments do not establish a single universal mechanism.
Why Model Conditions Matter
Oxidative stress can be induced in different ways.
A result in one cellular model may not reproduce in another tissue or under different experimental conditions.
What Can Be Concluded?
Pinealon peptide research provides preclinical evidence that EDR can influence ROS-related measurements in selected cell models.
Whether these effects translate into meaningful human outcomes remains unknown. Pinealon peptide research
3. Pinealon Peptide Research and Neuronal Cell Survival
Oxidative stress can contribute to neuronal injury.
Researchers have therefore examined whether Pinealon-associated changes in ROS correspond with differences in cell survival.
Cell Death and Neuronal Injury
Cells may die through several processes, including apoptosis and necrosis.
These mechanisms differ in their biochemical and structural characteristics.
What Did the 2011 Study Report?
The researchers observed reduced necrotic cell death in some experimental systems.
They used propidium iodide-based measurements to assess cell membrane integrity and related indicators of cell death.
What Is Propidium Iodide?
Propidium iodide is a fluorescent dye used in laboratory assays.
Its ability to enter cells is influenced by membrane integrity. Pinealon peptide research
It can therefore help identify cells with compromised membranes under appropriate experimental conditions.
Does Reduced Cell Death Prove Neuroprotection?
It supports a protective effect within the specific model.
However, it does not establish protection against all forms of neurological injury.
ERK1/2 Signalling
The investigators also reported changes in extracellular signal-regulated kinase signalling, commonly abbreviated ERK1/2.
ERK1/2 participates in cellular processes involving proliferation, differentiation and responses to environmental signals.
What Did the Researchers Observe?
The study described delayed ERK1/2 activation and changes in cell-cycle-associated measurements.
These observations suggested that Pinealon’s effects might extend beyond simple ROS reduction.
Does ERK Activation Always Improve Cell Survival?
No.
ERK signalling can produce different outcomes depending on the cell type, timing and experimental context.
Why Cell-Cycle Changes Require Caution
Mature neurons are generally non-dividing cells.
A change in cell-cycle markers does not necessarily indicate beneficial neuronal regeneration.
In some contexts, abnormal cell-cycle re-entry may be associated with neuronal stress.
The Evidence Boundary
Pinealon peptide research supports further investigation into cellular survival pathways.
It does not establish that Pinealon repairs damaged human neurons or reverses neurological disease.
4. Pinealon Peptide Research: DNA Binding and Gene-Regulation Hypotheses
One of the most distinctive aspects of the Pinealon literature concerns proposed interactions between short peptides and genetic material.
Researchers within the Khavinson-associated programme have examined whether short amino acid sequences can associate with DNA and influence gene-related processes.
Can Short Peptides Interact With DNA?
Some short peptides can interact with nucleic acids under laboratory conditions.
The strength and specificity of these interactions depend on molecular charge, sequence and experimental environment.
The 2011 Nuclear Localisation Study
A study examining short peptides reported that fluorescently labelled peptides could enter the nuclei of cultured HeLa cells.
The investigators also reported sequence-dependent interactions with DNA-related materials in vitro.
What Are HeLa Cells?
HeLa cells are a human-derived cancer cell line widely used in laboratory research.
Their cellular properties differ from those of normal human neurons.
Does Nuclear Entry Establish Gene Regulation?
No.
Detecting a labelled compound in a nucleus does not establish that it binds a specific gene or changes its expression.
What About DNA Binding?
Binding to isolated DNA in a laboratory assay is different from interacting with chromatin inside a living cell.
Cellular DNA is packaged with proteins, including histones, and exists in a highly regulated environment.
What Is Chromatin?
Chromatin is the complex of DNA and associated proteins found in the nucleus.
Its organisation contributes to gene accessibility and regulation.
Does Pinealon Directly Modify DNA?
There is insufficient evidence to conclude that Pinealon directly edits DNA or produces predictable, beneficial changes in human genes.
Is Pinealon an Epigenetic Treatment?
No clinically validated epigenetic treatment mechanism has been established for Pinealon.
The term epigenetic should not be used as a substitute for demonstrating a specific molecular pathway.
How Could Researchers Test the Hypothesis?
A rigorous investigation would require independent confirmation of cellular uptake, target engagement and reproducible changes in gene expression.
Researchers would also need to determine whether those changes produce meaningful functional outcomes.
Main Scientific Interpretation
Pinealon peptide research includes a plausible but incompletely validated hypothesis involving DNA-associated processes.
The available findings do not establish clinical gene regulation or genomic rejuvenation.
5. Pinealon Peptide Research in Hypoxia and Excitotoxicity Models
Hypoxia occurs when tissues or cells receive insufficient oxygen.
Because neurons are highly dependent on energy metabolism, hypoxic conditions can produce significant cellular stress.
What Is Hypobaric Hypoxia?
Hypobaric hypoxia involves reduced oxygen availability associated with lower atmospheric pressure.
Researchers use experimental models to examine physiological responses to these conditions.
The 2008 Animal Research
Kozina and colleagues examined several short regulatory peptides in a hypobaric hypoxia model.
The compounds included Pinealon and other peptides from the same research programme.
The authors reported that Pinealon demonstrated a comparatively pronounced effect in their experimental system.
What Mechanisms Were Proposed?
The investigators discussed endogenous antioxidant enzyme activity and possible changes in excitotoxic processes.
What Is Excitotoxicity?
Excitotoxicity refers to cellular injury associated with excessive excitatory signalling, often involving glutamate-related pathways.
It is relevant to several experimental models of neuronal stress.
What Is the NMDA Receptor?
The N-methyl-D-aspartate receptor is a glutamate receptor involved in neuronal signalling.
Its activity contributes to normal physiological processes, but excessive activation under certain conditions can contribute to cellular injury.
Does Pinealon Directly Block NMDA Receptors?
The cited study does not establish Pinealon as a clinically validated NMDA receptor antagonist.
The proposed relationship with excitotoxicity remains a mechanistic hypothesis.
What About Prenatal Hypoxia?
The researchers also discussed experiments involving prenatal hypoxic stress.
These findings relate to specific developmental and experimental contexts.
They cannot be generalised to human neurological disorders.
Can Pinealon Treat Stroke?
There is insufficient controlled human evidence to establish Pinealon as a treatment for stroke or other hypoxic brain injuries.
What Can Be Concluded?
Pinealon peptide research provides animal-model observations involving hypoxic stress.
These findings justify further investigation but do not demonstrate human therapeutic effectiveness.
6. Pinealon Peptide Research and Experimental Brain Ageing
The association between Pinealon and ageing research comes partly from its development within a programme examining short peptides and age-related biological processes.
Why Study Neuronal Ageing?
Ageing is associated with changes in cellular metabolism, gene regulation, inflammatory responses and neuronal structure.
However, these processes vary substantially between individuals and tissues.
What Are Dendritic Spines?
Dendritic spines are small protrusions on neuronal dendrites.
Many excitatory synapses are located on these structures.
Their number and morphology can change in response to neural activity and disease-related processes.
Pinealon and Neuronal Morphology
Some preclinical studies have examined whether Pinealon influences neuronal structural measurements, including dendritic spines.
Such work may help identify cellular processes worth investigating.
Does Spine Preservation Prove Better Memory?
No.
A structural measurement does not independently establish improved cognition.
Behavioural and functional outcomes require separate testing.
What About Alzheimer’s Disease Models?
Research groups have examined short peptides in experimental models associated with Alzheimer’s disease.
However, findings involving a particular animal model cannot establish effectiveness against human Alzheimer’s disease.
Why Genetic Models Have Limitations
Many animal models reproduce selected features of a human disorder rather than its full biological complexity.
A compound may influence one experimental feature without improving the overall disease process.
Does Pinealon Reverse Brain Ageing?
No reliable human clinical evidence establishes that Pinealon reverses brain ageing.
What About Biological Age Markers?
Some small human reports associated with the broader research programme discuss biological-age-related measurements.
These are not equivalent to demonstrating longer life, prevention of dementia or sustained improvement in neurological function.
Why Independent Replication Matters
Much of the Pinealon-specific literature comes from closely associated research groups.
Independent replication is needed to establish how robust and generalisable the reported effects are.
Scientific Interpretation
Pinealon peptide research raises questions about cellular responses associated with ageing, but claims of human rejuvenation exceed the available evidence.
7. Pinealon Peptide Research: Human Evidence, Safety and Regulatory Status
The most important distinction in the current evidence base is between preclinical findings and clinical effectiveness.
Has Pinealon Been Studied in Humans?
A small number of Russian-language reports have described human observations involving Pinealon or related peptide programmes.
Some included combinations of compounds rather than Pinealon alone.
Are There Large Randomised Trials?
No large, independently replicated randomised controlled trials establishing Pinealon’s effectiveness have been identified in the accessible published literature.
Why Combination Studies Are Difficult to Interpret
When two or more compounds are studied together, an observed outcome cannot reliably be attributed to one component without an appropriate experimental design.
What About Memory and Cognition?
Claims that Pinealon improves human memory or cognitive performance have not been established by robust controlled clinical evidence.
Is Pinealon FDA-Approved?
No.
Pinealon is not an FDA-approved medicine.
Is It an Approved Alzheimer’s Treatment?
No.
There is no established approval for treating Alzheimer’s disease or other neurodegenerative conditions.
What About Long-Term Safety?
Long-term human safety remains inadequately characterised.
Small observational reports cannot reliably establish uncommon adverse effects or long-term risks.
Is Pinealon Known to Cross the Blood–Brain Barrier?
A reliable human pharmacokinetic profile establishing how much intact Pinealon reaches the brain has not been demonstrated.
Its small molecular size alone does not prove effective brain exposure.
Why This Matters
A compound can produce effects when applied directly to cultured cells without achieving comparable concentrations in the human nervous system.
What Should Future Research Prioritise?
Independent replication, direct molecular target identification, pharmacokinetic characterisation and well-designed clinical trials are all needed.
The Evidence Boundary
Pinealon peptide research is primarily preclinical.
Its potential relevance to human neurological conditions remains a research question rather than an established therapeutic conclusion.
Pinealon Peptide Research: Evidence Strength by Application
| Research question | Available evidence | Appropriate conclusion |
|---|---|---|
| EDR chemical identity | Established structural data | Three-amino-acid peptide |
| ROS accumulation | Cell-culture experiments | Reduced accumulation reported in selected models |
| Necrotic cell death | Cell-based assays | Reduced cell death reported |
| ERK1/2 signalling | Preclinical experiments | Time-dependent changes observed |
| Nuclear localisation | Labelled-peptide experiments | Nuclear entry reported in a cell model |
| DNA-associated interactions | Biochemical experiments | Mechanistic hypothesis requiring further validation |
| Hypoxic stress | Animal experiments | Protective effects reported in selected models |
| Neuronal structural changes | Preclinical research | Model-dependent findings |
| Human cognition | Limited uncontrolled observations | Effectiveness not established |
| Long-term human safety | Insufficient evidence | Cannot be reliably determined |
| FDA approval | Regulatory status | No approved indication |
Pinealon Laboratory Testing: Identity, Purity and Stability
The reliability of Pinealon peptide research depends on accurate chemical identification.
Because EDR contains only three residues, sequence-related impurities and terminal modifications deserve particular attention.
Confirming Molecular Identity
Mass spectrometry can provide evidence consistent with the expected molecular mass.
Additional methods may be required to distinguish compounds with similar masses or altered residue arrangements.
HPLC Purity Testing
High-performance liquid chromatography can separate the intended peptide from certain impurities.
However, a chromatographic main-peak percentage does not establish absolute peptide content.
LC-MS Analysis
Liquid chromatography–mass spectrometry combines separation with mass-based detection.
It can support identification of the intended compound and selected degradation products.
Counterions and Water Content
A supplied peptide may contain counterions, residual water or other constituents.
These affect total sample mass.
Why Peptide Content Matters
Nominal vial mass and measured peptide content are not necessarily identical.
Laboratories should distinguish these measurements.
Sequence Verification
The sequence Glu–Asp–Arg should be distinguished from other tripeptides containing the same residues in different orders.
Stability Considerations
Peptide stability depends on the chemical form, formulation and environmental conditions.
Validated storage instructions should be based on material-specific data.
Batch Documentation
A useful Certificate of Analysis identifies the material, batch number, analytical methods and results.
Sterility and Endotoxins
Molecular identity and chromatographic purity do not establish sterility or endotoxin status.
These are separate quality attributes.
Why Analytical Controls Matter
If a sample contains related impurities, an experimental effect may be incorrectly attributed to intact Pinealon.
This is especially important when studying subtle changes in gene expression or cellular stress responses.
Worked Example: Interpreting a Pinealon Oxidative-Stress Experiment
Consider a hypothetical cell-culture study measuring relative ROS-associated fluorescence.
The experiment includes an untreated control, a stressed control and two experimental groups.
| Experimental condition | Hypothetical relative fluorescence |
|---|---|
| Untreated control | 1.00 |
| Stressed control | 2.80 |
| Experimental group A | 2.10 |
| Experimental group B | 1.65 |
These figures are fictional and are provided solely to illustrate scientific interpretation.
What Do the Measurements Suggest?
The stressed control shows higher fluorescence than the untreated control.
The experimental groups show lower fluorescence than the stressed control.
Does This Prove Direct ROS Scavenging?
No.
The differences could reflect several biological or assay-related mechanisms.
Does This Prove Improved Cell Survival?
No.
Cell viability would need to be measured separately.
What Additional Controls Would Help?
Relevant controls include assay-interference testing, independent ROS measurements, cell-viability assays and biological replication.
Does This Establish a Human Benefit?
No.
Cell-culture fluorescence measurements cannot establish improved human neurological health.
Main Lesson
Pinealon peptide research requires careful interpretation of experimental endpoints.
A measurable cellular change is not equivalent to demonstrated clinical effectiveness.
Pinealon Compared With Other Short Research Peptides
Pinealon belongs to a wider scientific discussion concerning short peptides and biological regulation.
However, similar peptide lengths do not establish similar mechanisms.
| Compound | Sequence or structure | Main research distinction |
|---|---|---|
| Pinealon | Glu–Asp–Arg (EDR) | Oxidative stress and proposed gene-associated processes |
| Epitalon | Ala–Glu–Asp–Gly (AEDG) | Telomere-related and ageing-associated experimental research |
| KPV | Lys–Pro–Val | Inflammatory signalling and peptide transport research |
| Selank | Thr–Lys–Pro–Arg–Pro–Gly–Pro | GABA-associated and neuroimmune research |
| Semax | Met–Glu–His–Phe–Pro–Gly–Pro | Neurotrophin and neurological signalling research |
Results from one peptide cannot automatically establish the effects of another.
Similarly, studies involving mixtures do not independently demonstrate the activity of each constituent.
Related Axion Peptide Lab Research Guides
Peptide Structure–Activity Relationships
Verify these proposed internal URLs before publishing them as active links.
Pinealon Research Materials at Axion Peptide Lab
Axion Peptide Lab provides a catalogue relevant to laboratory peptide research.
Researchers evaluating Pinealon should consult the current catalogue and review available specifications and batch documentation.
What Should Laboratories Verify?
Relevant attributes include the declared EDR sequence, chemical form, nominal content, batch identity and analytical methods.
Does High Purity Establish Biological Activity?
No.
Chromatographic purity does not independently establish a specific biological response.
Why Is Batch Identification Important?
Batch-specific records help laboratories connect experimental findings with the actual material tested.
Research-Only Distinction
Pinealon research materials should not be represented as approved medicines or clinically validated treatments for neurological disorders.
Frequently Asked Questions About Pinealon Peptide Research
1. What is Pinealon peptide research?
Pinealon peptide research examines the synthetic EDR tripeptide, particularly its effects on oxidative-stress measurements, neuronal cell models and proposed gene-associated mechanisms.
2. What is the Pinealon amino acid sequence?
The conventional sequence is Glu–Asp–Arg, abbreviated EDR.
3. What is the molecular weight of Pinealon?
The unmodified peptide has an approximate molecular mass of 418.4 Da.
4. Does Pinealon interact with DNA?
Experimental studies involving short peptides have reported DNA-associated interactions, but a specific clinically meaningful gene-regulatory mechanism for Pinealon has not been established in humans.
5. Does Pinealon reduce oxidative stress?
A 2011 cell study reported reduced ROS accumulation under defined experimental conditions. This does not establish a general human antioxidant benefit.
6. Has Pinealon been studied in brain injury models?
Yes. Preclinical research has examined Pinealon in models involving hypoxic stress and neuronal responses.
7. Is Pinealon proven to improve memory?
No. Reliable controlled clinical evidence establishing improved human memory is lacking.
8. Does Pinealon reverse brain ageing?
No. Claims of reversed human brain ageing are not supported by robust clinical evidence.
9. Is Pinealon FDA-approved?
No. Pinealon is not an FDA-approved medicine.
10. How can laboratories verify Pinealon quality?
Relevant methods include HPLC, LC-MS, sequence-related identity testing and batch-specific analytical documentation.
Conclusion: What Pinealon Peptide Research Establishes
Pinealon peptide research has produced findings involving oxidative stress, neuronal cell survival, ERK-associated signalling and experimental responses to hypoxia.
The chemical identity of the EDR tripeptide is well defined.
However, the biological evidence is considerably narrower than claims sometimes made about memory enhancement, neuroprotection or anti-ageing effects.
Cell studies have reported changes in ROS accumulation and viability. Animal experiments have also described responses under hypoxic conditions.
The proposed relationship with DNA and gene regulation remains an active mechanistic question rather than a clinically established pathway.
Independent replication and well-controlled human trials are needed before broader therapeutic conclusions can be drawn.
For laboratories, accurate peptide identification, suitable analytical controls and careful interpretation of model-specific findings remain essential.
Pinealon is a scientifically interesting short peptide, but its experimental findings should not be confused with established human neurological benefits.
Scientific References
- Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A. (2011). Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research.
https://doi.org/10.1089/rej.2011.1172 - Kozina LS, et al. (2008). Investigation of antihypoxic properties of short peptides. Advances in Gerontology.
https://pubmed.ncbi.nlm.nih.gov/18546825/ - Khavinson VKh, et al. (2011). Short peptides and sequence-dependent interactions with DNA-related materials. Biochemistry (Moscow).
https://doi.org/10.1134/S0006297911110022 - Khavinson VKh, et al. (2011). Effect of short peptides on expression of signalling molecules in organotypic pineal cell culture. Bulletin of Experimental Biology and Medicine.
https://doi.org/10.1007/s10517-011-1473-y - PubChem. Pinealon, compound CID 10273502.
https://pubchem.ncbi.nlm.nih.gov/compound/10273502 - PubMed. Pinealon biomedical research literature.
https://pubmed.ncbi.nlm.nih.gov/?term=Pinealon - ClinicalTrials.gov. Search for registered Pinealon studies.
https://clinicaltrials.gov/search?term=Pinealon
These references support the scientific discussion. They do not verify the identity, purity, safety or clinical suitability of independently supplied Pinealon research materials.
Research-use notice: This article is intended for scientific education and legitimate laboratory research. Axion Peptide Lab research materials are not intended for human or veterinary administration. Experimental findings should not be interpreted as medical advice, administration guidance or established claims of therapeutic benefit.